Category Archives: Biotech Companies Europe
AgileBio – collaborative tools that enhance research productivity
DDI-Predictor – predict drug drug interactions mediated by cytochromes
Agarose Bead Technologies – separation / purification products derived from agarose
Agarose Bead Technologies – separation / purification products derived from agarose
Newron Pharmaceuticals – innovative therapies for Central Nervous System
Newron Pharmaceuticals is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the Central Nervous System (CNS) and pain.
Newron Pharmaceuticals – innovative therapies for Central Nervous System
Kromaton – centrifugal partition chromatography
KROMATON is an innovating firm pioneer in Centrifugal Partition Chromatography (CPC), or Countercurrent Chromatography (CCC), a liquid/liquid preparative chromatography technique.
Kromaton – centrifugal partition chromatography
Bavarian Nordic – poxviral-based vaccine
Bavarian Nordic is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases.
Bavarian Nordic – poxviral-based vaccine
Bavarian Nordic has built its foundation around two poxviral-based vaccine platform technologies, Modified Vaccinia Ankara – Bavarian Nordic (MVA-BN) and Vaccinia-Fowlpox-TRICOM (VF-TRICOM) that have the potential to support a broad product pipeline in both infectious diseases and cancer immunotherapies. Both technologies can be manufactured at commercial scale at Bavarian Nordic’s own facility, which was recently expanded to accommodate the production of multiple products. Bavarian Nordic focuses on developing product candidates to address cancer and infectious diseases by leveraging several core strengths:
- Extensive R&D expertise in vaccines and immunotherapy
- Broadly applicable platform technology
- Multiple clinical stage development programs, including two Phase 3 trials
- Flexible, commercial scale manufacturing facility
- Significant financial resources resulting from IMVAMUNE supply contracts and government-funded R&D programs
Through a long-standing collaboration with the U.S. Government, Bavarian Nordic has developed a portfolio of biological countermeasures, including the non-replicating smallpox vaccine, IMVAMUNE, which is stockpiled for emergency use by the U.S. and other governments. The vaccine is approved in the EU (under the trade name IMVANEX) and in Canada. Bavarian Nordic and its partner Janssen are pioneering the development of an Ebola vaccine, which has been fast-tracked by authorities in response to the current situation in West Africa. Additionally, in collaboration with the National Cancer Institute, Bavarian Nordic has developed a portfolio of active cancer immunotherapies based on its versatile pox-virus based technologies, including PROSTVAC, which is currently in Phase 3 clinical development for the treatment of advanced prostate cancer. The company has partnered with Bristol-Myers Squibb for the potential commercialization of PROSTVAC.
Bavarian Nordic is a biotech company headquartered in Denmark, Germany and USA. Bavarian Nordic’s shares are listed on Nasdaq Copenhagen under the symbol BAVA (Reuters: BAVA.CO, Bloomberg: BAVA.DC). The company has a sponsored Level 1 ADR program listed in the US (OTC) under the symbol BVNRY.
More about Bavarian Nordic : www.bavarian-nordic.com
Bavarian Nordic – poxviral-based vaccine – poxviral – vaccine – PROSTVAC – IMVANEX – IMVAMUNE
Bavarian Nordic – poxviral-based vaccine – poxviral – vaccine – PROSTVAC – IMVANEX – IMVAMUNE
Cebiotex – drug delivery with electrospun nanofiber technology
Cebiotex offers manufacturing technology and contract research in the field of drug delivery with electrospun nanofiber technology.
Cebiotex – drug delivery with electrospun nanofiber technology
Poietis – 4D Bioprinting
Poietis is a biotech company whose mission is to design, develop and market innovative solutions based on 4D Bioprinting to support Researchers and Physicians in the emergence of personalized medicine.
Poietis – 4D Bioprinting
Bioinvent – antibody drug discovery
BioInvent is a research-based pharmaceutical company focused on discovery and development of innovative antibody-based drugs against cancer. BioInvent also develops antibody-based drugs in collaboration with partners who finance the development of new drugs and provide BioInvent with the right to milestone payments and royalties on sales.